Methods for prognosing the recurrence of gastrointestinal and other cancers using the Shc proteins

Details for Australian Patent Application No. 2006336255 (hide)

Owner Catalyst Oncology, Inc.

Inventors Frackelton Jr., Raymond A.; Hafer, Laurie Jean

Agent Griffith Hack

Pub. Number AU-A-2006336255

PCT Pub. Number WO2007/084156

Priority 60/760,900 20.01.06 US

Filing date 21 March 2006

Wipo publication date 26 July 2007

International Classifications

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

21 August 2008 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read FROM: Frackelton Jr., Raymond A. TO: Frackelton Jr., A. Raymond

21 August 2008 PCT application entered the National Phase

  PCT publication WO2007/084156 Priority application(s): WO2007/084156

25 September 2008 Alteration of Name

  The name of the applicant has been altered to Catalyst Oncology, LP 2007

20 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006336262-Molecular characterization with carbon nanotube control

2006336252-Multimodal biometric analysis